Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05924165 · ClinicalTrials.gov registry record · Phase 4
Narcotic-Free Percutaneous Nephrolithotomy
A Phase 4 study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- Phase 4
- Development phase
- 90
- Enrollment target
NCT05924165: Completed Phase 4 study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT05924165 is a Phase 4 study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 90 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05924165, a Phase 4 study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 90 participants
- Enrollment target
Study Summary
This is a randomized control trial comparing oral ketorolac and opioid medication for the use of post-operative analgesia.
Primary Outcome
Visual Analog Scale (VAS) to measure pain: The minimum score of '0' indicates "no pain" and the maximum score of '10' indicates "Worst pain imaginable" along a line. Participants will be asked to mark the level of their pain along the line. Visual analog scale (VAS) pain scores will be recorded
Interventions
- DRUG 5mg Oxycodone, Q6 PRN
- DRUG 10mg Ketorolac, Q6 PRN
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2023-05-19 |
| Est. Completion | 2025-01-07 |
| Phase | Phase 4 |
What the finished NCT05924165 record still lists
NCT05924165 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 2 interventions - of which 5mg Oxycodone, Q6 PRN is the first listed.
NCT05924165 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05924165 about?
NCT05924165 is a clinical study titled "Narcotic-Free Percutaneous Nephrolithotomy". This is a randomized control trial comparing oral ketorolac and opioid medication for the use of post-operative analgesia.
What is the current status of trial NCT05924165?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2023-05-19. Estimated completion is 2025-01-07.
What interventions are being tested in trial NCT05924165?
The interventions under investigation include: 5mg Oxycodone, Q6 PRN (DRUG), 10mg Ketorolac, Q6 PRN (DRUG).
Who is sponsoring clinical trial NCT05924165?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05924165's enrollment target sits among peer trials
90 886th of 2000 higher than 1,088 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI